Role for serial prenatal anti-Vel quantitative serologic monitoring with 2-ME serum treatment during pregnancy: case report
By:
Paid access
|Mar 2020Authors
W.J. Linz
Scott and White Transfusion Service and Donor Center, Assistant Professor of Pathology, Texas A&M UHSC, Temple, TX, United States
J.T. Fueger
Immunohematology Reference Laboratory, Diagnostic Laboratories, BloodCenter of Wisconsin, Milwaukee, WI, United States
S. Allen
Texas A&M UHSC/Scott and White Memorial Hospital, Department of Ob/Gyn, Division of Obstetrics and Gynecology, Scott & White Healthcare and Texas A&M University Health Science Center College of Medicine, Temple, TX, United States
S.T. Johnson
Immunohematology Reference Laboratory, Diagnostic Laboratories, BloodCenter of Wisconsin, Milwaukee, WI., United States
DOI: https://doi.org/10.21307/immunohematology-2019-194 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 8 - 10
Published on: Mar 12, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 W.J. Linz, J.T. Fueger, S. Allen, S.T. Johnson, published by American National Red Cross
This work is licensed under the Creative Commons License.